Welcome to our dedicated page for Healthstream SEC filings (Ticker: HSTM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
HealthStream filings document the regulatory record for a Tennessee healthcare technology company listed on Nasdaq under HSTM. Its 8-K filings report quarterly and annual operating results, Regulation FD disclosures, dividend declarations, share repurchase programs, acquisitions and amendments to its revolving credit agreement.
The company’s proxy materials cover board matters, executive compensation, equity awards and shareholder voting items under its governance framework and incentive plans. Material-event filings also document executive appointments and related compensatory arrangements, while exhibits to current reports provide formal press releases and agreement summaries tied to HealthStream’s capital allocation, financing and workforce-technology operations.
HealthStream Inc. director Charles Jr. Beard reported acquiring 1,249 shares of common stock through the vesting and conversion of restricted share units (RSUs). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs follow a three-year vesting schedule, contingent on continued service, and will vest annually in three equal installments beginning on May 29, 2026. After this transaction, Beard directly holds 1,249 shares of common stock and 2,500 RSUs.
HEALTHSTREAM INC director Dent Thompson increased his direct equity stake through equity compensation. On June 8, 2026, he acquired 3,148 shares of common stock at $0.00 per share upon vesting and conversion of restricted share units. Following these transactions, he directly holds 139,975 common shares.
HealthStream Inc. director Amir Alex Jahangir increased his equity stake through RSU vesting. On June 8, 2026, he acquired 3,148 shares of common stock upon the exercise of restricted share units, bringing his direct common stock holdings to 6,405 shares.
The filing shows multiple RSU awards, each representing the right to receive one share of common stock upon vesting. These RSUs follow three-year vesting schedules beginning on June 6, 2024, May 30, 2025, and May 29, 2026, contingent on continued service.
HEALTHSTREAM INC director Jeffrey L. McLaren reported acquiring shares through the vesting of restricted share units (RSUs). On June 8, 2026, RSU awards vested and delivered 3,148 shares of common stock, reflecting compensation rather than open‑market buying or selling.
Following these conversions, McLaren directly holds 25,748 shares of common stock and 2,032 RSUs. Each RSU represents a contingent right to receive one share of common stock upon vesting and is subject to a three‑year vesting schedule that requires continued service, with installments beginning on specific June and May dates in 2024, 2025, and 2026.
HealthStream director Terry Allison Rappuhn acquired 3,148 shares of common stock on June 8, 2026 through the vesting of restricted share units (RSUs). After these equity awards settled, she directly held 10,391 common shares, along with multiple RSU grants that continue to vest over three-year schedules tied to continued service.
HealthStream Inc. director Linda Rebrovick received 3,148 shares of common stock at no cost on vesting of restricted share units (RSUs). This award increased her direct common stock holdings to 57,329 shares.
The filing also shows exercises of RSUs into common stock across three grants, each RSU representing the right to receive one share upon vesting under multi-year vesting schedules contingent on continued service.
HealthStream director Deborah Taylor Tate acquired 3,148 shares of common stock through the vesting and conversion of restricted share units on June 8, 2026. Following these equity award exercises, she directly owns 24,699 common shares, and the RSUs vest on three‑year schedules contingent on continued service.
HealthStream director Frank Gordon reported routine equity compensation activity. On June 8, 2026, he acquired 3,148 shares of common stock through the vesting of restricted share units, a non-cash transaction recorded with code M for derivative exercise/conversion.
Following this vesting, Gordon directly holds 215,552 shares of HealthStream common stock. He also reports several indirect holdings, including shares held in a family trust, custodial accounts for minor children, and entities such as The Joel Company and Crofton Capital, reflecting ownership through related accounts rather than new market trades.
The footnotes explain that each restricted share unit represents the right to receive one share of common stock upon vesting and that these RSUs vest over a three year vesting schedule, contingent on continued service. The filing shows no open‑market purchases or sales, only the conversion of RSUs into common stock and updated indirect ownership positions.
HealthStream Inc. director Linda Rebrovick reported an open-market sale of company stock. On June 1, 2026, she sold 2,000 shares of HealthStream common stock at $25.00 per share.
After this transaction, she directly holds 54,181 shares of HealthStream common stock. The filing notes that the sale was made under a pre-arranged Rule 10b5-1 sales plan adopted on November 21, 2025.
HSTM submitted a Form 144 notice for the proposed sale of common stock. The filing lists a proposed sale by Linda Rebrovick of 2,000 shares dated 05/28/2026 with an amount shown as $50,000.00. The excerpt also lists stock awards dated 09/10/2021 (188 shares), 03/24/2014 (1,149 shares) and 04/26/2016 (663 shares), and names UBS Financial Services, Inc. as the broker.